Abstract: The compounds herein may be used to form an oral treatment composition. An oral treatment composition according to the present disclosure may comprise a mixture of different ingredients that when combined together result in an improved delivery mechanism to treat teeth and soft tissues of oral cavity. Generally the invention can be used to treat an oral disorder by delivering an oral treatment composition to a surface within the oral cavity, wherein the oral treatment composition comprises a hydrophobic active agent and a hydrophilic agent. The hydrophobic active agent may be a bacterial biofilm dispersion agent, a bacterial biofilm inhibitor, or a fatty acid signaling agent.

Abstract: A mixer and mixer assembly for turbulent mixing and enhancing a chemical reaction is provided. A method for using a mixer and mixer assembly for treatment of fluids is also provided. The mixer generally includes a first and second end, a surface configured for turbulent mixing, a catalyst supported thereon, and surface structure configured to increase interaction of catalyst and reactant. The mixer assembly generally includes a mixer inserted inside a fluid container or a tube and may also include a catalytic sleeve for enhancing interaction between catalyst and reactant.

Abstract: A mixer and mixer assembly for turbulent mixing and enhancing a chemical reaction is provided. A method for using a mixer and mixer assembly for treatment of fluids is also provided. The mixer generally includes a first and second end, a surface configured for turbulent mixing, a catalyst supported thereon, and surface structure configured to increase interaction of catalyst and reactant. The mixer assembly generally includes a mixer inserted inside a fluid container or a tube and may also include a catalytic sleeve for enhancing interaction between catalyst and reactant.

Abstract: Compositions and methods for local delivery of selectively targeted antimicrobials are disclosed for the treatment of periodontal disease by eliminating or significantly reducing specific pathogenic bacteria from the bacterial biofilm (plaque) occupying the gingival crevice or periodontal pocket. A carrier agent is utilized to allow for retention, penetration and sustained release.

Abstract: A tissue adhesive antimicrobial material that is placed into a tooth extraction site for the sustained release of silver for the prevention and treatment of alveolar osteitis. The antimicrobial material is placed into a tooth extraction site via syringe, hand instrument or hand delivery device.

Abstract: A mixer and mixer assembly for turbulent mixing and enhancing a chemical reaction is provided. A method for using a mixer and mixer assembly for treatment of fluids is also provided. The mixer generally includes a first and second end, a surface configured for turbulent mixing, a catalyst supported thereon, and surface structure configured to increase interaction of catalyst and reactant. The mixer assembly generally includes a mixer inserted inside a fluid container or a tube and may also include a catalytic sleeve for enhancing interaction between catalyst and reactant.

Abstract: A tissue adhesive antimicrobial material that is placed into a tooth extraction site for the sustained release of silver for the prevention and treatment of alveolar osteitis. The antimicrobial material is placed into a tooth extraction site via syringe, hand instrument or hand delivery device.

Abstract: The present invention relates to compositions and methods of treating periodontal disease and related disorders utilizing a sustained, controlled release targeted delivery method to effectively disrupt and inhibit bacterial biofilms at periodontal treatment sites.

Abstract: The present invention relates to compositions and methods of treating periodontal disease and related disorders utilizing a sustained, controlled release targeted delivery method to effectively disrupt and inhibit bacterial biofilms at periodontal treatment sites.

Abstract: The present invention relates to compositions and methods of treating periodontal disease and related disorders utilizing a sustained, controlled release targeted delivery method to effectively disrupt and inhibit bacterial biofilms at periodontal treatment sites.

Abstract: The invention relates to a method of treating periodontal disease and related disorders to regenerate lost tissues, which includes the steps of: combining at least one tissue regenerative agent with at least one cellular recognition agent to form a therapeutic treatment composition and applying the therapeutic treatment composition to a periodontal treatment site. The cellular recognition agent increases the periodontal tissue regeneration at the periodontal treatment site relative to the therapeutic treatment composition lacking the cellular recognition agent. The invention also includes the therapeutic composition.

Abstract: Compositions and methods for treating periodontal disease and other related disorders utilizing a therapeutic treatment composition, including at lease one chemotherapeutic agent in combination with at least one carrier agent, are disclosed. Oral care products and a method preventing periodontal disease and related disorders are also provided.

Abstract: An implant and method is disclosed using microparticles to provide a controlled, sustained release, and improved cellular uptake, of chemotherapeutic agents.

Abstract: A periodontal barrier and method incorporating chemotherapeutic agents is disclosed for aiding and guiding periodontal tissue regeneration.

Abstract: A periodontal barrier and method incorporating chemotherapeutic agents is disclosed for aiding and guiding periodontal tissue regeneration.

Abstract: A method for local delivery of chemotherapeutic agent (12) to a localized site in the mouth is disclosed. The method of delivery includes displacement or reflection of gingival tissues (20) from the tooth, in the area to be treated, to facilitate access to the periodontal lesion (16). A biodegradable, time-release microsphere (10) capsulating the chemotherapeutic agent is next positioned in the lesion (16). Accordingly, localized delivery of chemotherapeutic agent (12) continuously over a predetermined period of time is provided.